MedPath

Clinical study on the treatment of infertile patients with polycystic ovary syndrome with Ziyu fang

Phase 1
Not yet recruiting
Conditions
Polycystic ovary syndrome
Registration Number
ITMCTR2000004095
Lead Sponsor
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Married women aged 20 and 40 years;
2. Patients who meet the diagnostic criteria of traditional Chinese and Western medicine for polycystic ovary syndrome and infertility;
3. Patients who sign informed consent.

Exclusion Criteria

1. Patients who have used hormone drugs in the past 1 month;
2. Patients who have used other drugs affecting reproductive or metabolic function (such as anti-obesity drugs, anti-diabetes drugs and Traditional Chinese medicine) or who have participated in other clinical trials in recent 2 months;
3. There are other infertility factors, such as male semen abnormalities, female reproductive tract abnormalities, fallopian tube factors;
4. Patients who cannot cooperate in completing the research plan, including those with a history of infectious diseases, mental illness or other diseases.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.